-+ 0.00%
-+ 0.00%
-+ 0.00%

Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 million

PUBT·07/23/2026 23:35:27
Listen to the news
Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 million
  • Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins exercised options for 284,800 common shares at USD 6.55 on July 21, 2026.
  • Robins sold 492,400 common shares the same day at weighted-average prices of USD 21.72 and USD 22.12.
  • Directly held common shares fell to 812,058 following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780851-26-000017), on July 23, 2026, and is solely responsible for the information contained therein.